Laggards through the market rally, health-care stocks offer a fine blend of value and growth, says Barron’s Mike Santoli.
Hot Stocks: Pharmaceuticals
Drug companies’ stocks climb Monday after Abbott Laboratories says it will buy the pharmaceutical unit of Solvay for about $7 billion. MarketWatch’s Christopher Hinton reports.
Discussion
View Comments for “A Cheery Prognosis for Health-Care Stocks”